Abstract
ABSTRACT Protein glycosylation in prokaryotes shows extraordinary diversity including species-specific monosaccharides, non-canonical attachment sites, and variable glycan architectures that challenge existing glycoproteomics approaches. Current strategies are largely tailored to eukaryotic systems and depend on predefined glycan databases or prior biochemical knowledge, limiting their application to microbes. Here we present NovoGlyco, a modular glycoproteomics platform for untargeted characterisation of prokaryotic protein glycosylation from shotgun proteomics data. NovoGlyco integrates de novo oxonium ion discovery, sequence tag matching, and mass offset binning to identify novel glycans, their composition, and linking chemistry. An interactive dashboard allows exploration of glycan features and modified proteins. We demonstrate the NovoGlyco platform across published glycoproteomics datasets, spanning human pathogens, Asgard archaea, and environmental enrichment cultures, and identify previously unreported flagella O-glycans in the opportunistic pathogen Campylobacter fetus . In summary, NovoGlyco provides a scalable framework for unbiased exploration of microbial glycoproteomes in both single-organism and metaproteomic contexts.
Full text
1,379 characters
· extracted from
oa-html
· click to expand
ABSTRACT
Protein glycosylation in prokaryotes shows extraordinary diversity including species-specific monosaccharides, non-canonical attachment sites, and variable glycan architectures that challenge existing glycoproteomics approaches. Current strategies are largely tailored to eukaryotic systems and depend on predefined glycan databases or prior biochemical knowledge, limiting their application to microbes. Here we present NovoGlyco, a modular glycoproteomics platform for untargeted characterisation of prokaryotic protein glycosylation from shotgun proteomics data. NovoGlyco integrates de novo oxonium ion discovery, sequence tag matching, and mass offset binning to identify novel glycans, their composition, and linking chemistry. An interactive dashboard allows exploration of glycan features and modified proteins. We demonstrate the NovoGlyco platform across published glycoproteomics datasets, spanning human pathogens, Asgard archaea, and environmental enrichment cultures, and identify previously unreported flagella O-glycans in the opportunistic pathogen Campylobacter fetus. In summary, NovoGlyco provides a scalable framework for unbiased exploration of microbial glycoproteomes in both single-organism and metaproteomic contexts.
Competing Interest Statement
The authors have declared no competing interest.
Footnotes
↵* contacts: soic{at}imsb.biol.ethz.ch
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.